CALL FOR PAPERS Sex and Gender Differences in Pain and Inflammation Sex differences in morphine-induced analgesia of visceral pain are supraspinally and peripherally mediated

s Abstract viewer: 294.5, 2005. 40. Ji Y, Tang B, and Traub RJ. Estrogen increases and progesterone decreases behavioral and neuronal responses to colorectal distention following colonic inflammation in the rat. Pain 117: 433–442, 2005. 41. Jonsson E, Coombs DW, Hunstad D, Richardson JR Jr, von Reyn CF, Saunders RL and Heaney JA. Continuous infusion of intrathecal morphine to control acquired immunodeficiency syndrome-associated bladder pain. J Urol 147: 687–689, 1992. 42. Joris JL, Dubner R, and Hargreaves KM. Opioid analgesia at peripheral sites: a target for opioids released during stress and inflammation? Anesth Analg 66: 1277–1281, 1987. 43. Kalyuzhny AE, Arvidsson U, Wu W, and Wessendorf MW. mu-Opioid and delta-opioid receptors are expressed in brainstem antinociceptive circuits: studies using immunocytochemistry and retrograde tract-tracing. J Neurosci 16: 6490–6503, 1996. 44. Kelly MJ, Lagrange AH, Wagner EJ, and Ronnekleiv OK. Rapid effects of estrogen to modulate G protein-coupled receptors via activation of protein kinase A and protein kinase C pathways. Steroids 64: 64–75, 1999. 45. Kelly MJ, Loose MD, and Ronnekleiv OK. Estrogen suppresses muopioidand GABAB-mediated hyperpolarization of hypothalamic arcuate neurons. J Neurosci 12: 2745–2750, 1992. 46. Kepler KL, Kest B, Kiefel JM, Cooper ML, and Bodnar RJ. Roles of gender, gonadectomy and estrous phase in the analgesic effects of intracerebroventricular morphine in rats. Pharmacol Biochem Behav 34: 119– 127, 1989. 47. Kepler KL, Standifer KM, Paul D, Kest B, Pasternak GW, and Bodnar RJ. Gender effects and central opioid analgesia. Pain 45: 87–94, 1991. 48. Kest B, Sarton E, and Dahan A. Gender differences in opioid-mediated analgesia: animal and human studies. Anesthesiology 93: 539–547, 2000. 49. Kest B, Wilson SG, and Mogil JS. Sex differences in supraspinal morphine analgesia are dependent on genotype. J Pharmacol Exp Ther 289: 1370–1375, 1999. 50. Khasabova IA, Harding-Rose C, Simone DA, and Seybold VS. Differential effects of CB1 and opioid agonists on two populations of adult rat dorsal root ganglion neurons. J Neurosci 24: 1744–1753, 2004. 51. Kolesnikov Y and Pasternak GW. Topical opioids in mice: analgesia and reversal of tolerance by a topical N-methyl-D-aspartate antagonist. J Pharmacol Exp Ther 290: 247–252, 1999. 52. Kolesnikov YA, Jain S, Wilson R, and Pasternak GW. Peripheral morphine analgesia: synergy with central sites and a target of morphine tolerance. J Pharmacol Exp Ther 279: 502–506, 1996. 53. Kroin JS, Buvanendran A, Nagalla SK, and Tuman KJ. Postoperative pain and analgesic responses are similar in male and female SpragueDawley rats. Can J Anaesth 50: 904–908, 2003. 54. Krzanowska EK and Bodnar RJ. Morphine antinociception elicited from the ventrolateral periaqueductal gray is sensitive to sex and gonadectomy differences in rats. Brain Res 821: 224–230, 1999. 55. Lagrange AH, Ronnekleiv OK, and Kelly MJ. The potency of muopioid hyperpolarization of hypothalamic arcuate neurons is rapidly attenuated by 17 beta-estradiol. J Neurosci 14: 6196–6204, 1994. 56. Lagrange AH, Ronnekleiv OK, and Kelly MJ. Modulation of G proteincoupled receptors by an estrogen receptor that activates protein kinase A. Mol Pharmacol 51: 605–612, 1997. 57. Larsson M, Arvidsson S, Ekman C, and Bayati A. A model for chronic quantitative studies of colorectal sensitivity using balloon distension in R313 SEX DIFFERENCES IN MORPHINE ANALGESIA OF VISCERAL PAIN AJP-Regul Integr Comp Physiol • VOL 291 • AUGUST 2006 • www.ajpregu.org on A uust 6, 2006 ajpreguysiology.org D ow nladed fom conscious mice—effects of opioid receptor agonists. Neurogastroenterol Motil 15: 371–381, 2003. 58. Leighton BL, DeSimone CA, Norris MC, and Ben David B. Intrathecal narcotics for labor revisited: the combination of fentanyl and morphine intrathecally provides rapid onset of profound, prolonged analgesia. Anesth Analg 69: 122–125, 1989. 59. Loyd D, Wang X, and Murphy AZ. Morphine injection into the periaqueductal gray produces a sexually dimorphic response in a model of persistent inflammatory pain. Society for Neuroscience Abstracts Abstract viewer: 394.3, 2005. 60. Millan MJ. Descending control of pain. Prog Neurobiol 66: 355–474, 2002. 61. Miller PL and Ernst AA. Sex differences in analgesia: a randomized trial of mu versus kappa opioid agonists. South Med J 97: 35–41, 2004. 62. Ness TJ and Gebhart GF. Colorectal distention as a noxious visceral stimulus: physiologic and pharmacologic characterization of pseudaffective responses in the rat. Brain Res 450: 153–169, 1988. 63. Ozaki N, Sengupta JN, and Gebhart GF. Differential effects of mu-, delta-, and kappa-opioid receptor agonists on mechanosensitive gastric vagal afferent fibers in the rat. J Neurophysiol 83: 2209–2216, 2000. 64. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates. San Diego: Academic, 1986. 65. Qiu J, Bosch MA, Tobias SC, Grandy DK, Scanlan TS, Ronnekleiv OK, and Kelly MJ. Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C. J Neurosci 23: 9529–9540, 2003. 66. Ratka A and Simpkins JW. Effects of estradiol and progesterone on the sensitivity to pain and on morphine-induced antinociception in female rats. Horm Behav 25: 217–228, 1991. 67. Sarton E, Olofsen E, Romberg R, Den Hartigh J, Kest B, Nieuwenhuijs D, Burm A, Teppema L, and Dahan A. Sex differences in morphine analgesia—an experimental study in healthy volunteers. Anesthesiology 93: 1245–1254, 2000. 68. Sato T, Sakurada S, Takahashi N, Sakurada T, Tan-No K, Wako K, and Kisara K. Contribution of spinal mu1-opioid receptors to morphineinduced antinociception. Eur J Pharmacol 369: 183–187, 1999. 69. Schinkel AH, Wagenaar E, Mol CA, and van Deemter L. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest 97: 2517–2524, 1996. 70. Sengupta JN, Snider A, Su X, and Gebhart GF. Effects of kappa opioids in the inflamed rat colon. Pain 79: 175–185, 1999. 71. Shin SW and Eisenach JC. Intrathecal morphine reduces the visceromotor response to acute uterine cervical distension in an estrogen-independent manner. Anesthesiology 98: 1467–1471, 2003. 72. Smith MT, Watt JA, and Cramond T. Morphine-3-glucuronide–a potent antagonist of morphine analgesia. Life Sci 47: 579–585, 1990. 73. Stander S, Gunzer M, Metze D, Luger T, and Steinhoff M. Localization of mu-opioid receptor 1A on sensory nerve fibers in human skin. Regul Pept 110: 75–83, 2002. 74. Stein C. Peripheral mechanisms of opioid analgesia. Anesth Analg 76: 182–191, 1993. 75. Stein C. The control of pain in peripheral tissue by opioids. N Engl J Med 332: 1685–1690, 1995. 76. Stein C, Millan MJ, Yassouridis A, and Herz A. Antinociceptive effects of muand kappa-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism. Eur J Pharmacol 155: 255–264,